A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
Michael H. Davidson, Judith Johnson, Michael W. Rooney, Michael L. Kyle, Douglas F. KlingVolume:
6
Year:
2012
Language:
english
DOI:
10.1016/j.jacl.2012.01.002
File:
PDF, 856 KB
english, 2012